Could tiny devices implanted on nerves be used one day to make drugs more effective, or to even replace them? GSK is betting millions on these “bioelectronics” — and partnering with Google’s Verily to make them a reality.
from Forbes – Tech http://ift.tt/2aoSGZQ
via IFTTT